0000905718-17-000463.txt : 20170412
0000905718-17-000463.hdr.sgml : 20170412
20170412111416
ACCESSION NUMBER: 0000905718-17-000463
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
ITEM INFORMATION: Investment Company Act Section 3(c)
ITEM INFORMATION: Section 3(c)(7)
FILED AS OF DATE: 20170412
DATE AS OF CHANGE: 20170412
EFFECTIVENESS DATE: 20170412
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: NAM Special Situations Fund I QP, LLC (FBIO Series I)
CENTRAL INDEX KEY: 0001702316
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-283712
FILM NUMBER: 17757308
BUSINESS ADDRESS:
STREET 1: 410 PARK AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
BUSINESS PHONE: 212-417-8033
MAIL ADDRESS:
STREET 1: 410 PARK AVENUE, 14TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10022
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001702316
NAM Special Situations Fund I QP, LLC (FBIO Series I)
410 PARK AVENUE, 14TH FLOOR
NEW YORK
NY
NEW YORK
10022
646-414-6965
DELAWARE
None
None
Limited Liability Company
true
2017
-
NAM Biotech Management LLC
410 Park Avenue, 14th Floor
New York
NY
NEW YORK
10022
Executive Officer
Manager
-
National Asset Management, Inc.
410 Park Avenue, 14th Floor
New York
NY
NEW YORK
10022
Executive Officer
Advisor
David
Levine
c/o National Asset Management, Inc.
410 Park Avenue, 14th Floor
New York
NY
NEW YORK
10022
Executive Officer
Pooled Investment Fund
Venture Capital Fund
false
Decline to Disclose
- 06b
- 3C
- 3C.7
true
0000905718-17-000415
2017-03-31
false
true
false
0
National Securities Corporation
7569
None
None
ONE UNION SQUARE, 600 UNIVERSITY STREET
SUITE 2900
SEATTLE
WA
WASHINGTON
98101
All States
false
50000000
1804000
48196000
false
10
5000000
true
0
Assumes maximum commissions earned equal to 10% of gross proceeds. Excludes 5-year cash only placement agent warrants as set forth in the offering materials.
0
true
false
NAM Special Situations Fund I QP, LLC (FBIO Series I)
/s/ David Levine
David Levine
Authorized Signatory
2017-04-12